Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind,

S Grinspoon1, C Corcoran, H Askari

  • 1Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

Abstract

Insights

Testosterone therapy can help men with AIDS wasting syndrome regain lean body mass and improve their quality of life. This study found significant gains in muscle mass and overall well-being with testosterone treatment.

Area of Science:

  • Endocrinology
  • HIV/AIDS Medicine
  • Metabolic Research

Background:

  • AIDS wasting syndrome is characterized by significant lean body mass loss, impacting survival.
  • Hypogonadism (low testosterone) affects over half of men with advanced HIV disease.
  • The role of testosterone deficiency in AIDS wasting remains unclear.

Purpose of the Study:

  • To evaluate the impact of physiological testosterone administration on body composition.
  • To assess effects on exercise capacity and quality of life in androgen-deficient men with AIDS wasting.
  • To determine if testosterone can reverse muscle loss in this population.

Main Methods:

  • A randomized, double-blind, placebo-controlled study was conducted at a university medical center.
  • 51 HIV-positive men with wasting and low testosterone levels received either testosterone enanthate (300 mg every 3 weeks) or placebo for 6 months.
  • Primary endpoint was change in fat-free mass; secondary endpoints included lean body mass, muscle mass, exercise capacity, and quality of life.

Main Results:

  • Testosterone-treated patients showed significant gains in fat-free mass (2.0 kg vs. -0.6 kg), lean body mass (1.9 kg vs. 0.0 kg), and muscle mass (2.4 kg vs. -0.8 kg) compared to placebo.
  • No significant differences were observed in weight, fat mass, or exercise functional capacity between groups.
  • Testosterone recipients reported improved quality of life, feeling better, and enhanced appearance.

Conclusions:

  • Physiological testosterone administration is effective in increasing lean body mass in men with AIDS wasting syndrome.
  • Testosterone therapy improves the quality of life for androgen-deficient men experiencing AIDS wasting.
  • Testosterone treatment was well-tolerated and showed positive effects on body composition and well-being.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...